These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 9136072)

  • 21. Subgroup identification based on differential effect search--a recursive partitioning method for establishing response to treatment in patient subpopulations.
    Lipkovich I; Dmitrienko A; Denne J; Enas G
    Stat Med; 2011 Sep; 30(21):2601-21. PubMed ID: 21786278
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Futility interim monitoring with control of type I and II error probabilities using the interim Z-value or confidence limit.
    Lachin JM
    Clin Trials; 2009 Dec; 6(6):565-73. PubMed ID: 19933716
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Two-stage adaptive designs with correlated test statistics.
    Hommel G; Lindig V; Faldum A
    J Biopharm Stat; 2005; 15(4):613-23. PubMed ID: 16022167
    [TBL] [Abstract][Full Text] [Related]  

  • 24. How to deal with multiple treatment or dose groups in randomized clinical trials?
    Hothorn LA
    Fundam Clin Pharmacol; 2007 Apr; 21(2):137-54. PubMed ID: 17391286
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Blinded sample size recalculation for clinical trials with normal data and baseline adjusted analysis.
    Friede T; Kieser M
    Pharm Stat; 2011; 10(1):8-13. PubMed ID: 19943322
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Group sequential t-test for clinical trials with small sample sizes across stages.
    Shao J; Feng H
    Contemp Clin Trials; 2007 Sep; 28(5):563-71. PubMed ID: 17434814
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mega-trials vs. meta-analysis: precision vs. heterogeneity?
    Shrier I; Platt RW; Steele RJ
    Contemp Clin Trials; 2007 May; 28(3):324-8. PubMed ID: 17188025
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reporting and interpreting adjuvant therapy clinical trials. International Breast Cancer Study Group (formerly Ludwig Group).
    Gelber RD; Goldhirsch A
    J Natl Cancer Inst Monogr; 1992; (11):59-69. PubMed ID: 1385720
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Can trial sequential monitoring boundaries reduce spurious inferences from meta-analyses?
    Thorlund K; Devereaux PJ; Wetterslev J; Guyatt G; Ioannidis JP; Thabane L; Gluud LL; Als-Nielsen B; Gluud C
    Int J Epidemiol; 2009 Feb; 38(1):276-86. PubMed ID: 18824467
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Consistency of lipid-altering effects of ezetimibe/simvastatin across gender, race, age, baseline low density lipoprotein cholesterol levels, and coronary heart disease status: results of a pooled retrospective analysis.
    Ose L; Shah A; Davies MJ; Rotonda J; Maccubbin D; Tribble D; Veltri E; Mitchel Y
    Curr Med Res Opin; 2006 May; 22(5):823-35. PubMed ID: 16709304
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Methods for the statistical analysis of binary data in split-mouth designs with baseline measurements.
    Donner A; Zou GY
    Stat Med; 2007 Aug; 26(18):3476-86. PubMed ID: 17149800
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rationale for a non-inferiority clinical trial design focused on subpopulations.
    Kulkarni PM; Meadows ES; Ahuja S; Muram D; Plouffe L
    Curr Med Res Opin; 2004 Oct; 20(10):1641-7. PubMed ID: 15462697
    [TBL] [Abstract][Full Text] [Related]  

  • 33. On the timing of a futility analysis in clinical trials.
    Pallay A
    J Biopharm Stat; 2000 Aug; 10(3):399-405. PubMed ID: 10959919
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Sequential analysis in clinical and epidemiological research].
    van der Tweel I; Schipper M
    Ned Tijdschr Geneeskd; 2002 Dec; 146(49):2348-52. PubMed ID: 12510397
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Does early improvement triggered by antidepressants predict response/remission? Analysis of data from a naturalistic study on a large sample of inpatients with major depression.
    Henkel V; Seemüller F; Obermeier M; Adli M; Bauer M; Mundt C; Brieger P; Laux G; Bender W; Heuser I; Zeiler J; Gaebel W; Mayr A; Möller HJ; Riedel M
    J Affect Disord; 2009 Jun; 115(3):439-49. PubMed ID: 19027961
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [V: p values: what they do tell and what they don't...].
    Krummenauer F
    Klin Monbl Augenheilkd; 2002 Dec; 219(12):896-8. PubMed ID: 12548477
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Variable selection for clustering with Gaussian mixture models.
    Maugis C; Celeux G; Martin-Magniette ML
    Biometrics; 2009 Sep; 65(3):701-9. PubMed ID: 19210744
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sample size determination using an interim analysis.
    Bristol DR
    J Biopharm Stat; 1993 Sep; 3(2):159-66. PubMed ID: 8220401
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multiplicity-adjusted sample size requirements: a strategy to maintain statistical power with Bonferroni adjustments.
    Leon AC
    J Clin Psychiatry; 2004 Nov; 65(11):1511-4. PubMed ID: 15554764
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Addressing and advancing the problem of missing data.
    Walton MK
    J Biopharm Stat; 2009 Nov; 19(6):945-56. PubMed ID: 20183457
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.